Back to Agenda
The Promise and Reality of Clinical Trial Transparency Initiatives
Session Chair(s)
Thomas Wicks, MBA
Chief Strategy Officer
Citeline, United States
The past decade has seen a virtual explosion of trial disclosure requirements and expectations around the world. This panel discussion will discuss the successes, challenges, and opportunities for improvement, looking back over the past ten years and forward to the expected developments in the next five.
Speaker(s)
Panel Discussion
Karla Childers, MS
Johnson & Johnson, United States
Head, Bioethics-Based Science and Technology Policy
Panel Discussion
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Panel Discussion
Joao Ferreira, PharmD
European Medicines Agency, Netherlands
Clinical Data Publication Manager
Panel Discussion
Sini Eskola, MPharm, MS, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Director Regulatory Strategy
Panel Discussion
Deborah Lincow
Bioethics International, United States
Associate
Have an account?